What Microdose Psychedelic Insights does

Microdose Psychedelic Insights (legal entity: MD Media Inc.) is a privately held digital media company founded in 2019 and headquartered in Toronto, Canada, though incorporated in the United States. It publishes Microdose.buzz, a category-dedicated news platform covering the psychedelic medicine industry across six verticals: industry, finance, culture, politics/law, science, and wellness. The reporting operation is led by journalist Madison Roberts and the company operates with an 11–50 employee footprint under a bootstrapped, founder-operated structure with no disclosed institutional funding. The company has built substantial editorial distribution through daily news, newsletters, social channels, and an award-winning documentary, 'The World on Drugs,' which earned official selections at five international film festivals in 2022.

The company operates four distinct product surfaces: (1) the Microdose.Buzz news platform as the core media asset, (2) store.microdose.buzz, a curated e-commerce marketplace selling functional mushroom products and branded merchandise priced $19–$69, (3) Science of Psychedelics (scienceofpsychedelics.com), a partnered online learning platform delivering CE-accredited professional courses in psychedelic medicine (MDMA, classic psychedelics, addiction treatment, ketamine, microdosing, and counseling), and (4) the 'World on Drugs' documentary franchise. The underlying technology is a WordPress/web-based content management system layered with an e-commerce storefront and an LMS for course delivery — a deliberately lean stack appropriate to a focused content-and-commerce media business rather than a deep-tech platform.

Revenue is generated through three streams: advertising and sponsorships sold against the news audience, transactional e-commerce sales via the curated marketplace, and one-time course license fees from the CE-accredited learning platform. The customer base spans four personas — mental health professionals (primary, purchasing CE courses), psychedelic industry professionals (investors/executives consuming news and deal flow), psychedelic-curious consumers (purchasing marketplace merchandise), and researchers/advocates (consuming regulatory and research coverage). Geographic reach is positioned as global via digital distribution, with explicit event-driven reach into 100+ countries through Global Psychedelic Week.

Name

Microdose Psychedelic Insights

Legal name

MD Media Inc.

Website

https://microdose.buzz

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Microdose Psychedelic Insights is a privately held digital media company publishing industry news, a curated functional-mushroom marketplace, and CE-accredited professional courses for the psychedelic medicine sector. It serves mental health professionals, industry investors, and psychedelic-curious consumers globally.

Ownership category

akta.pro rank

Product category

Specialty Digital Media

akta.pro primary industry

Topic/Interest-Based Content Discovery Apps (MPACAKAB)

akta.pro secondary industry

Microlearning & Short-Form Lesson Platforms (MPACALAE)

Keywords

• Psychedelic industry news
• Digital media publishing
• Online education courses
• Wellness marketplace
• Industry event coverage

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Online Course Sales: CE-accredited professional training courses in psychedelic medicine sold through scienceofpsychedelics.com platform, with courses ranging from 65-90 minutes covering topics like MDMA, microdosing, ketamine, and psychedelic counseling.
2. E-commerce Marketplace: Curated marketplace (store.microdose.buzz) selling functional mushroom products, merchandise including apparel, accessories, and wellness products ranging from $19-$69.
3. Advertising and Sponsorships: Advertising options across platforms as noted in the site's 'Advertise with us' section, reaching the psychedelic industry audience.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Microdose Psychedelic Insights operates a digital news media platform covering the psychedelics industry across science, finance, culture, politics, and wellness categories. The company also runs an e-commerce marketplace selling functional mushroom products, sleep gummies, apparel, and psychedelic-themed merchandise, and offers CE-accredited professional training courses in psychedelic medicine through its Science of Psychedelics online learning platform.

Product overview

Microdose Psychedelic Insights operates primarily as a digital news and media company focused on psychedelic medicine coverage. The core offerings include the Microdose Buzz news platform (covering industry news, finance, culture, science, law/politics, and health/wellness), an e-commerce marketplace (selling functional mushroom products, gummies, apparel, and merchandise), online educational courses through Science of Psychedelics (offering CE-accredited training in psychedelic medicine topics), and The World on Drugs documentary. The company positions itself as a guide to psychedelics with a mission to shift the world's perception of psychedelic medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• Microdose Buzz News Platform Digital news and media platform covering the psychedelics industry across categories including Industry, Finance, Culture, Politics, Science, and Wellness. Provides articles, breaking news coverage, analysis, and editorial content about psychedelic medicine developments, clinical trials, regulatory changes, and cultural topics.
• Microdose Marketplace Curated e-commerce marketplace offering functional mushroom products, sleep gummies, apparel, accessories, and psychedelic-themed merchandise. Products include Eons brand items (such as Sleep Mushroom Gummies at $36) and branded merchandise (such as Tripping Backpack at $69, SHROOMS Hoodie at $54) ranging from $19 to $69.
• Science of Psychedelics Online Courses CE-accredited professional training courses in psychedelic medicine covering topics including MDMA therapy for PTSD (90 minutes), Mechanisms of Action for Classic Psychedelics (65 minutes), Psychedelic Counseling Foundations (75 minutes), Ketamine for Depression and Mood Disorders (80 minutes), Psychedelic Treatment of Addiction, and Microdosing Psychedelics. Courses are delivered through the Science of Psychedelics platform.
• The World on Drugs Documentary

Quantifiable outcome

• Extensive coverage of major industry events including AbbVie's $1B psychedelic bet and MAPS cannabis research developments
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered minor and core.

• MycoMedica Life SciencesminorOthers · 13 November 2024Enveric Biosciences licensed its EVM201 program including EB-002 to MycoMedica Life Sciences. This is covered by Microdose as industry news, not a direct partnership.
• Aries Science & TechnologyminorOthers · 13 November 2024Enveric Biosciences licensing partner for encapsulation technologies. Covered as industry news by Microdose.
• Science of PsychedelicscoreStrategic or Co-development PartnerScience of Psychedelics (scienceofpsychedelics.com) is Microdose's partner for delivering CE-accredited professional training courses in psychedelic medicine. This platform hosts courses on MDMA, psilocybin, ketamine, microdosing, addiction treatment, and psychedelic counseling.
• Eons LifeminorChannel Partner/ Reseller/ DistributorEons Life products including Deeper Sleep Tablets and Sleep Mushroom Gummies are sold through Microdose's marketplace. Eons Life produces liposomal mushroom sleep aids.
• Global Psychedelic WeekminorGTM or Marketing PartnerMicrodose covers and promotes Global Psychedelic Week events. November 2025 event brought together thought leaders from over 100 countries with hybrid online and in-person sessions.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Psychedelic Alpha: Subscription-based financial intelligence and data platform covering the psychedelic medicine industry. Directly comparable as a niche digital media outlet focused on psychedelic industry news, deal flow, and company analysis — competing for the same investor and professional audience.
• DoubleBlind Magazine: Digital and print magazine covering psychedelic culture, harm reduction, and drug policy. Comparable as a psychedelic-focused content brand serving enthusiasts and professionals with editorial coverage and educational content.
• Psychedelics Today: Podcast- and education-led platform covering psychedelic research, therapy, and culture, including a paid training program (the Vital program). Directly comparable as a psychedelic media company offering news, courses, and community — overlapping with Microdose's course and content business.
• Third Wave: Educational platform offering microdosing courses, coaching certifications, and a curated directory of psychedelic resources. Comparable business model — combines editorial content, paid online courses, and a product/resource marketplace targeting psychedelic-curious consumers and professionals.
• Chacruna Institute: Nonprofit hosting the Psychedelic Plant Medicines Conference and publishing cultural/ethnobotanical content. Comparable as a psychedelic education and events organizer with adjacent content monetization, though operating under a nonprofit structure.
• Reset.me: Independent online publication covering psychedelic news, science, and personal stories. Comparable as a long-running psychedelic-focused digital media property, though smaller in scope and lacking the course/marketplace diversification that Microdose has built.
• Lucid News: Digital publication covering psychedelic science, policy, culture, and business. Directly comparable as a niche psychedelic industry media outlet targeting professionals and engaged enthusiasts with editorial content.
• Psychedelic Science Review: Peer-reviewed-style publication covering psychedelic research and clinical developments, often tied to academic and clinical audiences. Comparable as a specialized psychedelic content platform with educational positioning, though more clinically focused than Microdose's multi-vertical approach.

Broad incumbents

• MAPS (Multidisciplinary Association for Psychedelic Studies): The pioneering psychedelic research and advocacy nonprofit that has driven much of the regulatory and clinical agenda. Comparable in that it dominates psychedelic education and policy content at scale, but operates from a research/advocacy base rather than as a commercial media company.

Regional players

• Cannabis Now: Established cannabis-focused digital media and events company. Comparable as a legal-psychoactive-substance vertical media business with a similar mix of news, culture, product marketplace, and events — operating primarily in the adjacent cannabis space with looser federal regulatory status.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/microdosehq
• LinkedInlinkedin.com/company/microdosehq

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Microdose Psychedelic Insights